Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Enzon Pharmaceuticals Inc

CUSIP: 293904908 | 2 institutional holders

Quarters

Q4 2015 Q3 2015 Q2 2015 Q1 2015 Q4 2014

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile